According to China stock market news choice, 520 companies have successfully landed in the A-share market since the beginning of last year (February 16). Among them, the share prices of 72 companies still fall below the issue price, accounting for 14.04% of the total number of companies issuing A-Shares during the period. The industry is mainly distributed in the fields of medicine, biology, electronics and basic chemical industry.
Further statistics found that among the above 72 companies that fell below the issue price, 28 companies’ share prices fell by more than 20% compared with the issue price. Among them, Aojie Technology (- 44.58%), Maiwei Biology (- 38.76%), Baiji Shenzhou (- 38.11%), Dizhe medicine (- 37.98%) and Liaoning Chengda Biotechnology Co.Ltd(688739) (- 37.00%) ranked among the top five in terms of decline compared with the issue price. According to the listing time, 22 listed companies broke more than 20% in 2021 and 6 listed companies broke more than 20% in 2022. Among them, Maiwei biology is the latest one to be listed. The listing date is January 18, 2022, and its issue price is 34.8 yuan / share. As of the closing on February 16, the company’s share price is 21.31 yuan / share, a decrease of nearly 38.76% compared with the issue price.
